Susquehanna International Group’s Franklin Genomic Advancements ETF HELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,934
Closed -$227K 6034
2024
Q1
$227K Sell
6,934
-582
-8% -$19.1K ﹤0.01% 4541
2023
Q4
$229K Buy
+7,516
New +$229K ﹤0.01% 4848